PP01.138: Real-World Effectiveness and Safety of Lurbinectedin for Small Cell Lung Cancer (SCLC): Updates From Jazz EMERGE 402

Authors

• Firas Badin
• Philip Lammers
• Geoffrey Liu
• Leonid Shunyakov
• Steven Madden
• Shaqil Kassam
• Mehul Patel, Rochester Regional HealthFollow
• Nagaprasad Nagajothi
• Yan Ji
• Catherine Labbe
• Dennis Slater
• Viral Rabara
• Mehmood Hashmi
• Shaker Dakhil
• Matthias Weiss
• John Migas
• Navit Naveh
• Douglas S. Fuller
• Wenyan Li
• Badri Rengarajan
• Balazs Halmos

Department

Oncology and Hematology

Document Type

Conference Proceeding

Publication Title

Journal of Thoracic Oncology

Conference Name

North America Conference on Lung Cancer

Conference Date

2025-12-05 - 2025-12-07

First Page

103868

DOI

10.1016/j.jtho.2026.103868

Volume

21

Issue

5, Supplement 1

Publication Date

5-1-2026

Recommended Citation

Badin, F., Lammers, P., Liu, G., Shunyakov, L., Madden, S., Kassam, S., Patel, M., Nagajothi, N., Ji, Y., Labbe, C., Slater, D., Rabara, V., Hashmi, M., Dakhil, S., Weiss, M., Migas, J., Naveh, N., Fuller, D. S., Li, W., Rengarajan, B., & Halmos, B. (2026). PP01.138: Real-World Effectiveness and Safety of Lurbinectedin for Small Cell Lung Cancer (SCLC): Updates From Jazz EMERGE 402. Journal of Thoracic Oncology, 21 (5, Supplement 1), 103868. https://doi.org/10.1016/j.jtho.2026.103868